AEON Biopharma (AEON) Price & Analysis

Q: What was Aeon Biopharma, Inc.’s price range in the past 12 months?

Aeon Biopharma, Inc. lowest stock price was $0.38 and its highest was $115.56 in the past 12 months.

Q: What is Aeon Biopharma, Inc.’s market cap?

Aeon Biopharma, Inc.’s market cap is $9.08M.

Q: When is Aeon Biopharma, Inc.’s upcoming earnings report date?

Aeon Biopharma, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 93 days.

Q: How were Aeon Biopharma, Inc.’s earnings last quarter?

Aeon Biopharma, Inc. released its earnings results on Aug 12, 2025. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.35 by -$0.25.

Q: Is Aeon Biopharma, Inc. overvalued?

According to Wall Street analysts Aeon Biopharma, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Aeon Biopharma, Inc. pay dividends?

Aeon Biopharma, Inc. does not currently pay dividends.

Q: What is Aeon Biopharma, Inc.’s EPS estimate?

Aeon Biopharma, Inc.’s EPS estimate is -0.43.

Q: How many shares outstanding does Aeon Biopharma, Inc. have?

Aeon Biopharma, Inc. has 11,643,786 shares outstanding.

Q: What happened to Aeon Biopharma, Inc.’s price movement after its last earnings report?

Aeon Biopharma, Inc. reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.35. Following the earnings report the stock price went up 15.942%.

Q: Which hedge fund is a major shareholder of Aeon Biopharma, Inc.?

Among the largest hedge funds holding Aeon Biopharma, Inc.’s share is Saba Capital Management. It holds Aeon Biopharma, Inc.’s shares valued at 0.

Compare

211 Followers

AEON Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.38 - $115.56

Previous CloseN/A

Volume17.80M

Average Volume (3M)112.42K

Market Cap

$9.08M

Enterprise Value$16.43M

Total Cash (Recent Filing)$10.45M

Total Debt (Recent Filing)$14.60M

Price to Earnings (P/E)<0.1

Beta2.09

Next Earnings

Nov 18, 2025

EPS Estimate

-0.43

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.60

Shares Outstanding11,643,786

10 Day Avg. Volume104,248

30 Day Avg. Volume112,417

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.81

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-0.77

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Bulls Say, Bears Say

Bulls Say

Cost ManagementR&D expenses declined 50.8% YoY to $4.4M, which were below the estimate, indicating effective cost management.

Regulatory ApprovalAeon finds alignment with the FDA on key biosimilar pathway requirements, boosting confidence in potential regulatory approval.

Bears Say

Funding UncertaintyGiven the uncertainty in funding, the price target is adjusted to $5 from $6, reflecting potential financial challenges.

Production DependencyAeon relies on Daewoong to manufacture ABP-450, and any production issues with Daewoong could adversely impact Aeon.

AEON Biopharma News

Aeon Biopharma Advances Biosimilar Development

Aeon Biopharma, Inc. ( ($AEON) ) has released its Q2 earnings. Here is a breakdown of the information...

4d ago

AEON

AEON Biopharma Holds Annual Stockholders Meeting

AEON Biopharma ( ($AEON) ) has shared an update. On June 13, 2025, AEON Biopharma, Inc. held its...

2M ago

AEON

Aeon Biopharma Reports Positive Q1 2025 Earnings

Aeon Biopharma, Inc. ( ($AEON) ) has released its Q1 earnings. Here is a breakdown of the information...

3M ago

AEON

AEON Biopharma Releases New Corporate Presentation

An announcement from AEON Biopharma ( ($AEON) ) is now available. On May 20, 2025, AEON Biopharma released...

3M ago

AEON

AEON Biopharma Appoints New CEO Robert Bancroft

AEON Biopharma ( ($AEON) ) has provided an announcement. On April 19, 2025, AEON Biopharma appointed Robert Bancroft...

4M ago

AEON

Aeon Biopharma appoints Rob Bancroft as CEO

Aeon Biopharma (AEON) announced the appointment of Rob Bancroft as president and CEO, effective April 29. Bancroft will...

4M ago

AEON

AEON Biopharma Appoints Jost Fischer as Interim CEO

AEON Biopharma ( ($AEON) ) has shared an update. On April 3, 2025, AEON Biopharma‘s board appointed Jost...

4M ago

AEON

AEON Biopharma’s Strategic Progress and Financial Turnaround

Aeon Biopharma, Inc. ( ($AEON) ) has released its Q4 earnings. Here is a breakdown of the information...

5M ago

AEON

AEON Biopharma Announces CEO Resignation and Interim Appointment

AEON Biopharma ( ($AEON) ) just unveiled an announcement. AEON Biopharma, Inc. announced that its President and CEO,...

5M ago

AEON

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

5M ago

AEON

APRE

AEON Biopharma Releases New Corporate Presentation

AEON Biopharma ( ($AEON) ) just unveiled an announcement. On March 10, 2025, AEON Biopharma made available a...

5M ago

AEON

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

6M ago

PFE

AEON

AEON Biopharma Stockholders Approve Key Proposals

AEON Biopharma ( ($AEON) ) just unveiled an update. At a recent Special Meeting, AEON Biopharma’s stockholders approved...

6M ago

AEON

Aeon Biopharma prices 40M units at 50c in underwritten public offering

AEON Biopharma (AEON) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the...

7M ago

AEON

AEON FAQ

What was Aeon Biopharma, Inc.’s price range in the past 12 months?

Aeon Biopharma, Inc. lowest stock price was $0.38 and its highest was $115.56 in the past 12 months.

What is Aeon Biopharma, Inc.’s market cap?

Aeon Biopharma, Inc.’s market cap is $9.08M.

When is Aeon Biopharma, Inc.’s upcoming earnings report date?

Aeon Biopharma, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 93 days.

How were Aeon Biopharma, Inc.’s earnings last quarter?

Aeon Biopharma, Inc. released its earnings results on Aug 12, 2025. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.35 by -$0.25.

Is Aeon Biopharma, Inc. overvalued?

According to Wall Street analysts Aeon Biopharma, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aeon Biopharma, Inc. pay dividends?

Aeon Biopharma, Inc. does not currently pay dividends.

What is Aeon Biopharma, Inc.’s EPS estimate?

Aeon Biopharma, Inc.’s EPS estimate is -0.43.

How many shares outstanding does Aeon Biopharma, Inc. have?

Aeon Biopharma, Inc. has 11,643,786 shares outstanding.

What happened to Aeon Biopharma, Inc.’s price movement after its last earnings report?

Aeon Biopharma, Inc. reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.35. Following the earnings report the stock price went up 15.942%.

Which hedge fund is a major shareholder of Aeon Biopharma, Inc.?

Among the largest hedge funds holding Aeon Biopharma, Inc.’s share is Saba Capital Management. It holds Aeon Biopharma, Inc.’s shares valued at 0.

Company Description

Aeon Biopharma, Inc.

AEON Biopharma (AEON) is a clinical-stage biopharmaceutical company that focuses on developing and commercializing therapeutic treatments targeting neurological and gastroenterological disorders. The company is engaged in the research and development of therapeutic applications for botulinum toxin complex, aiming to address unmet medical needs in various indications such as chronic migraine, cervical dystonia, and other related conditions.